BriaCell Therapeutics Corp. (BCTX)

BriaCell Therapeutics Statistics

Total Valuation

BCTX has a market cap or net worth of $24.97 million. The enterprise value is $23.81 million.

Market Cap	24.97M
Enterprise Value	23.81M

Important Dates

The next estimated earnings date is Thursday, December 12, 2024, after market close.

Earnings Date	Dec 12, 2024
Ex-Dividend Date	n/a

Share Statistics

BCTX has 35.84 million shares outstanding. The number of shares has increased by 5.35% in one year.

Current Share Class	35.84M
Shares Outstanding	35.84M
Shares Change (YoY)	+5.35%
Shares Change (QoQ)	+11.84%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	28.70M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	n/a
P/FCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.49

Current Ratio	0.49
Quick Ratio	0.21
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-126.11%
Return on Capital (ROIC)	n/a
Revenue Per Employee	n/a
Profits Per Employee	-$299,467
Employee Count	16
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -83.60% in the last 52 weeks. The beta is 1.83, so BCTX's price volatility has been higher than the market average.

Beta (5Y)	1.83
52-Week Price Change	-83.60%
50-Day Moving Average	0.80
200-Day Moving Average	1.73
Relative Strength Index (RSI)	40.99
Average Volume (20 Days)	1,104,674

Short Selling Information

The latest short interest is 727,572, so 2.03% of the outstanding shares have been sold short.

Short Interest	727,572
Short Previous Month	449,187
Short % of Shares Out	2.03%
Short % of Float	2.54%
Short Ratio (days to cover)	0.14

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-33.33M
Pretax Income	-6.04M
Net Income	-4.79M
EBITDA	-33.25M
EBIT	-33.33M
Earnings Per Share (EPS)	-$0.29

Balance Sheet

Cash & Cash Equivalents	862,089
Total Debt	n/a
Net Cash	862,089
Net Cash Per Share	$0.02
Equity (Book Value)	-2.68M
Book Value Per Share	-0.13
Working Capital	-3.81M

Cash Flow

In the last 12 months, operating cash flow was -$24.13 million and capital expenditures -$456,801, giving a free cash flow of -$24.58 million.

Operating Cash Flow	-24.13M
Capital Expenditures	-456,801
Free Cash Flow	-24.58M
FCF Per Share	-$0.69

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

BCTX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-5.35%
Shareholder Yield	-5.35%
Earnings Yield	-19.19%
FCF Yield	-98.46%

Analyst Forecast

The average price target for BCTX is $15.00, which is 2,027.66% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$15.00
Price Target Difference	2,027.66%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Splits

The last stock split was on January 2, 2020. It was a reverse split with a ratio of 0.0033333:1.

Last Split Date	Jan 2, 2020
Split Type	Reverse
Split Ratio	0.0033333:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a